Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serplulimab (HLX10) plus Chemotherapy in Advanced Squamous NSCLC (ASTRUM-004)
NCT04033354Phase 3Unknown
- Sponsor
- Henlius
- Start
- Aug 2019
- Primary completion
- Dec 2023
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 7
01
Overview
A Phase 3 trial of serplulimab in squamous cell carcinoma of the lung (SCCL), sponsored by Henlius. Status: unknown.
02
Drugs
serplulimab
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT04033354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033354.